Industry Symposiums

Friday, 28 October

Addressing matters of the heart for your Type 2 Diabetes patients

Presented by Jean Vorster

Saturday, 29 October

Is there a silver bullet solution for the management of cardio-metabolic patients?

A high proportion of patients with hypertension have other comorbidities such as dyslipidaemia and/ or CAD. There is a clear need to improve the care of CVD patients as CVD is one of the leading causes of morbidity and mortality in the world. The aim of the symposium is to support healthcare practitioners to consistently and accurately interpret clinical evidence and latest treatment guidelines so that they can make informed decisions when it comes to the treatment of their patients with CVD.

Presented by Dr. Marshall Heradien

Dr. Marshall Heradien is a specialist cardiologist, he is in part time private practice at Netcare Kuilsriver Hospital. He has a dedicated interest in refractory hypertension and is highly experienced with interventional renal ablation therapy. He has also performed extensive research on the topic, investigating not only its role in hypertension, but also in other cardiac diseases, e.g. atrial fibrillation.

Dr Heradien is also an external lecturer/clinical tutor (Internal Medicine) at Tygerberg Hospital and holds a PhD in Internal Medicine.

Dr Heradien has received various awards throughout his career, including the Hamilton Naki Clinical Scholarship in 2016.

Saturday, 29 October

LDL – C: How low should you go?

Presented by Dr. Anthony Dalby

Dr Tony Dalby is a Cardiologist at Life Fourways Hospital in Randburg. He was the South African National Lead Investigator in the Odyssey Outcomes trial. His presentation will emphasise the need for lipid lowering treatment to be commenced earlier, to be sufficiently intensive and to be sustained over the long haul.

Sunday, 30 October

Heart Failure Continuum: Empagliflozin in the Acute HF Setting.

Heart Failure contributes to some of the biggest morbidities and causes of mortality in our society. Boehringer Ingelheim is committed to being a partner in finding solutions on how to address the burden of disease, across Ejection Fractions. The symposium aims to share the most recent data relating to management of patients with cardiovascular disease and Heart Failure, with special focus to the role SGLT2 inhibitor Empagliflozin in the management of acute heart failure.

Presented by Dr. Martin Mpe & Dr. Jens Hitzeroth

Dr. Martin Mpe
Cardiologist
President HeFSSA
Executive Committee SA Hypertension Society

Dr. Jens Hitzeroth
Cardiologist
Executive Committee HeFSSA

For any queries, kindly contact: Dr. Lerato Marivate| 072 374 4536
lerato.marivate@boehringer-Ingelheim.com

Congress Venue

Sandton Convention Centre
161 Maude Street, Sandton, Gauteng
South Africa
saheart@eventoptions.co.za

About the Sandton Convention Centre

Sandton Convention Centre is the Premier Exhibition, Conference & Events Destination in Africa and South Africa’s leading event venue, offering prestigious multi-use event spaces and venues in the financial hub of Johannesburg. It is conveniently located in the vibrant business district of Sandton in northern Johannesburg and within easy reach of the Gautrain and O. R. Tambo International Airport. The Sandton Convention Centre (SCC) is flanked by a number of leading hotels, sophisticated shopping centres and entertainment complexes.